Nifty
Sensex
:
:
14529.15
49099.99
-568.20 (-3.76%)
-1939.32 (-3.80%)

Pharmaceuticals & Drugs - Domestic

Rating :
64/99

BSE: 506943 | NSE: JBCHEPHARM

1118.60
26-Feb-2021
  • Open
  • High
  • Low
  • Previous Close
  •  1130.00
  •  1206.30
  •  1107.05
  •  1138.45
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  239015
  •  2759.05
  •  1263.00
  •  415.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 8,634.34
  • 21.72
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 8,635.43
  • 0.98%
  • 5.31

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 55.91%
  • 0.96%
  • 19.70%
  • FII
  • DII
  • Others
  • 7.87%
  • 13.23%
  • 2.33%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 7.14
  • 7.58
  • 7.87

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.98
  • 12.88
  • 13.65

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.92
  • 11.04
  • 25.28

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 17.77
  • 17.21
  • 17.81

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.12
  • 2.52
  • 2.68

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 9.91
  • 10.73
  • 10.93

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 20
Dec 19
Var%
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Net Sales
548.22
428.63
27.90%
443.56
456.42
-2.82%
522.29
446.11
17.08%
443.57
418.91
5.89%
Expenses
377.22
339.04
11.26%
333.47
356.16
-6.37%
366.86
350.13
4.78%
351.83
353.38
-0.44%
EBITDA
170.99
89.59
90.86%
110.10
100.26
9.81%
155.42
95.98
61.93%
91.74
65.54
39.98%
EBIDTM
31.19%
20.90%
24.82%
21.97%
29.76%
21.51%
14.01%
15.65%
Other Income
55.95
16.38
241.58%
8.39
18.51
-54.67%
22.69
12.61
79.94%
3.17
15.65
-79.74%
Interest
1.09
0.85
28.24%
1.72
0.87
97.70%
3.75
0.80
368.75%
0.50
1.31
-61.83%
Depreciation
17.39
16.75
3.82%
17.45
16.39
6.47%
17.29
15.80
9.43%
17.39
11.60
49.91%
PBT
208.46
88.37
135.89%
99.33
101.51
-2.15%
157.07
91.99
70.75%
67.02
68.28
-1.85%
Tax
54.18
21.93
147.06%
25.41
7.75
227.87%
37.57
29.87
25.78%
16.95
21.49
-21.13%
PAT
154.28
66.45
132.17%
73.92
93.76
-21.16%
119.51
62.11
92.42%
50.07
46.79
7.01%
PATM
28.14%
15.50%
16.67%
20.54%
22.88%
13.92%
7.11%
11.17%
EPS
19.94
8.26
141.40%
9.55
11.67
-18.17%
15.45
7.73
99.87%
28.29
5.82
386.08%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
1,957.64
1,774.73
1,643.20
1,413.77
1,368.32
1,231.58
1,144.21
1,021.86
866.13
801.87
890.79
Net Sales Growth
11.86%
8.00%
16.23%
3.32%
11.10%
7.64%
11.97%
17.98%
8.01%
-9.98%
 
Cost Of Goods Sold
5,151.08
630.80
596.46
542.41
552.00
491.41
341.40
413.95
371.52
320.07
277.04
Gross Profit
-3,193.44
1,143.93
1,046.74
871.35
816.32
740.17
802.81
607.92
494.60
481.80
613.75
GP Margin
-163.13%
64.46%
63.70%
61.63%
59.66%
60.10%
70.16%
59.49%
57.10%
60.08%
68.90%
Total Expenditure
1,429.38
1,397.15
1,337.36
1,214.64
1,135.93
1,025.55
964.09
873.67
760.48
701.55
698.43
Power & Fuel Cost
-
61.54
63.29
58.28
54.89
55.28
53.02
46.61
39.75
29.89
23.34
% Of Sales
-
3.47%
3.85%
4.12%
4.01%
4.49%
4.63%
4.56%
4.59%
3.73%
2.62%
Employee Cost
-
322.92
288.18
251.10
217.34
175.31
159.56
143.67
130.05
112.66
124.93
% Of Sales
-
18.20%
17.54%
17.76%
15.88%
14.23%
13.94%
14.06%
15.02%
14.05%
14.02%
Manufacturing Exp.
-
140.70
150.49
139.83
131.45
119.35
223.53
102.44
61.75
52.97
60.85
% Of Sales
-
7.93%
9.16%
9.89%
9.61%
9.69%
19.54%
10.02%
7.13%
6.61%
6.83%
General & Admin Exp.
-
48.89
52.97
53.96
42.26
34.82
32.46
31.69
27.94
31.31
38.21
% Of Sales
-
2.75%
3.22%
3.82%
3.09%
2.83%
2.84%
3.10%
3.23%
3.90%
4.29%
Selling & Distn. Exp.
-
116.95
113.59
87.44
78.27
72.72
75.13
73.59
56.04
68.65
131.60
% Of Sales
-
6.59%
6.91%
6.18%
5.72%
5.90%
6.57%
7.20%
6.47%
8.56%
14.77%
Miscellaneous Exp.
-
75.36
72.38
81.61
59.72
76.65
79.01
61.72
73.44
86.00
131.60
% Of Sales
-
4.25%
4.40%
5.77%
4.36%
6.22%
6.91%
6.04%
8.48%
10.72%
4.77%
EBITDA
528.25
377.58
305.84
199.13
232.39
206.03
180.12
148.19
105.65
100.32
192.36
EBITDA Margin
26.98%
21.28%
18.61%
14.09%
16.98%
16.73%
15.74%
14.50%
12.20%
12.51%
21.59%
Other Income
90.20
50.90
41.44
55.29
50.16
56.65
10.89
37.70
27.87
28.98
6.16
Interest
7.06
3.26
4.65
3.49
5.37
10.65
6.82
5.93
5.28
24.03
10.49
Depreciation
69.52
66.32
55.64
56.97
47.22
41.22
38.64
28.02
24.66
22.42
22.79
PBT
531.88
358.89
286.99
193.95
229.94
210.82
145.55
151.94
103.57
82.85
165.24
Tax
134.11
76.50
93.02
55.23
45.55
49.58
45.14
25.95
24.13
165.53
25.92
Tax Rate
25.21%
21.93%
32.41%
28.48%
19.81%
23.52%
31.01%
29.68%
23.30%
19.63%
15.69%
PAT
397.78
272.04
193.47
138.34
184.06
161.14
100.41
61.50
79.44
677.91
139.32
PAT before Minority Interest
397.42
272.39
193.97
138.72
184.40
161.24
100.41
61.50
79.44
677.91
139.32
Minority Interest
-0.36
-0.35
-0.50
-0.38
-0.34
-0.10
0.00
0.00
0.00
0.00
0.00
PAT Margin
20.32%
15.33%
11.77%
9.79%
13.45%
13.08%
8.78%
6.02%
9.17%
84.54%
15.64%
PAT Growth
47.81%
40.61%
39.85%
-24.84%
14.22%
60.48%
63.27%
-22.58%
-88.28%
386.58%
 
EPS
51.46
35.19
25.03
17.90
23.81
20.85
12.99
7.96
10.28
87.70
18.02

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
1,435.49
1,480.12
1,441.56
1,363.67
1,183.84
994.87
1,042.81
1,020.27
969.95
691.54
Share Capital
15.46
16.05
16.71
16.96
16.96
16.96
16.95
16.94
16.94
16.90
Total Reserves
1,420.03
1,464.08
1,424.84
1,346.70
1,166.87
977.91
1,025.82
1,003.22
952.83
674.31
Non-Current Liabilities
62.72
64.84
45.66
26.98
31.02
32.62
31.93
40.45
39.52
36.50
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.09
0.22
0.40
0.54
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.40
0.40
7.03
12.14
11.99
Long Term Provisions
7.39
5.73
9.67
12.56
10.43
12.03
12.19
8.23
8.27
7.71
Current Liabilities
515.77
781.54
736.50
693.46
797.22
459.75
276.27
239.48
188.32
271.33
Trade Payables
123.79
117.37
110.39
98.98
90.85
77.51
60.75
60.51
37.09
50.21
Other Current Liabilities
143.88
93.10
119.75
122.15
138.73
103.74
98.06
101.15
78.75
61.22
Short Term Borrowings
32.04
25.80
29.29
48.86
193.02
126.88
81.71
37.28
55.23
133.36
Short Term Provisions
216.06
545.27
477.06
423.47
374.61
151.62
35.76
40.54
17.26
26.54
Total Liabilities
2,016.48
2,329.30
2,226.49
2,086.29
2,013.75
1,487.24
1,351.01
1,300.20
1,197.79
999.37
Net Block
651.26
620.93
639.50
679.44
440.22
328.56
310.55
334.41
276.31
258.39
Gross Block
1,177.43
1,084.83
1,053.76
1,038.55
753.75
601.67
540.54
537.46
456.51
420.25
Accumulated Depreciation
526.17
463.89
414.25
359.10
313.53
273.11
229.99
203.06
180.19
161.85
Non Current Assets
740.83
740.80
717.89
879.15
831.58
586.31
370.37
356.49
331.58
278.78
Capital Work in Progress
16.17
15.09
17.40
3.76
134.89
55.17
46.36
4.81
39.00
3.75
Non Current Investment
69.45
95.88
49.96
185.84
231.42
184.83
2.75
2.99
3.00
3.94
Long Term Loans & Adv.
3.59
8.31
10.15
9.43
22.63
17.74
10.71
14.28
13.27
12.70
Other Non Current Assets
0.36
0.59
0.88
0.67
2.43
0.00
0.00
0.00
0.00
0.00
Current Assets
1,275.65
1,588.51
1,508.59
1,207.14
1,182.16
900.94
980.65
943.71
866.22
720.60
Current Investments
333.81
360.65
383.77
224.96
247.28
366.78
497.26
394.68
298.92
81.05
Inventories
274.67
243.76
213.73
200.17
187.98
150.27
134.40
104.53
101.03
111.67
Sundry Debtors
345.43
308.22
300.73
265.97
272.64
262.35
235.51
191.27
136.05
345.58
Cash & Bank
30.95
36.80
29.92
13.39
12.90
25.19
11.81
156.23
219.53
126.89
Other Current Assets
290.80
33.23
12.94
14.36
461.34
96.35
101.68
96.99
110.69
55.41
Short Term Loans & Adv.
272.33
605.85
567.50
488.30
458.83
95.97
101.48
96.84
110.29
54.66
Net Current Assets
759.88
806.97
772.10
513.68
384.94
441.19
704.37
704.23
677.90
449.27
Total Assets
2,016.48
2,329.31
2,226.48
2,086.29
2,013.74
1,487.25
1,351.02
1,300.20
1,197.80
999.38

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
275.37
194.33
122.92
201.13
140.41
126.66
-13.98
84.20
879.69
133.92
PBT
348.89
286.99
193.95
229.94
212.23
145.55
87.44
103.57
843.44
165.34
Adjustment
7.95
23.72
16.91
13.11
-1.40
38.51
20.75
-4.40
33.13
16.60
Changes in Working Capital
9.32
-51.47
-47.07
5.92
-16.96
-19.52
-93.71
9.47
167.35
-15.87
Cash after chg. in Working capital
366.17
259.24
163.79
248.97
193.88
164.53
14.49
108.65
1,043.91
166.07
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-90.80
-64.91
-40.87
-47.84
-53.47
-37.87
-28.47
-24.45
-164.22
-32.15
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
24.30
-27.67
-20.68
-45.31
-27.62
-111.89
-142.50
-116.05
-260.92
-89.46
Net Fixed Assets
-94.42
-29.82
-29.56
-152.86
-187.76
-69.64
-55.43
-41.77
-69.55
-32.72
Net Investments
53.26
-22.80
-22.92
67.89
-14.16
-61.38
-102.46
-95.95
-214.42
-60.83
Others
65.46
24.95
31.80
39.66
174.30
19.13
15.39
21.67
23.05
4.09
Cash from Financing Activity
-306.05
-155.74
-59.52
-183.84
-99.62
-1.39
12.04
-31.45
-526.12
4.56
Net Cash Inflow / Outflow
-6.38
10.92
42.72
-28.02
13.17
13.38
-144.43
-63.30
92.65
49.02
Opening Cash & Equivalents
32.14
21.24
-21.47
6.54
-5.46
11.81
156.23
219.53
126.89
77.86
Closing Cash & Equivalent
25.75
32.14
21.24
-21.47
9.42
25.19
11.81
156.23
219.53
126.89

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
185.75
184.47
172.50
160.77
139.57
117.31
123.07
119.21
113.34
80.86
ROA
12.54%
8.52%
6.43%
8.99%
9.21%
7.08%
4.64%
6.36%
61.71%
15.17%
ROE
18.69%
13.28%
9.89%
14.48%
14.80%
9.86%
5.99%
8.07%
82.49%
22.35%
ROCE
23.69%
19.59%
13.70%
16.87%
17.72%
13.49%
8.50%
10.41%
92.09%
22.63%
Fixed Asset Turnover
1.57
1.54
1.35
1.53
1.82
2.03
1.92
1.76
1.85
2.22
Receivable days
67.22
67.63
73.15
71.84
79.28
78.41
75.30
68.16
108.62
140.48
Inventory Days
53.31
50.81
53.43
51.77
50.12
44.83
42.16
42.80
47.97
39.77
Payable days
32.74
32.21
33.66
32.86
32.45
27.82
26.91
26.15
26.89
25.89
Cash Conversion Cycle
87.79
86.23
92.93
90.75
96.95
95.43
90.54
84.81
129.69
154.35
Total Debt/Equity
0.02
0.02
0.02
0.04
0.16
0.13
0.09
0.05
0.07
0.25
Interest Cover
108.09
62.74
56.54
43.81
20.80
22.33
15.74
20.61
36.10
16.75

News Update:


  • JB Chemicals gets USFDA's nod for Loratadine Tablets
    8th Jan 2021, 16:24 PM

    The Company expects to commercialize this product in Q1 of FY 2021-22 and is expected to improve Company's US sales

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.